TY - JOUR T1 - Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins. JF - Nat Commun Y1 - 2014 A1 - Postmus, Iris A1 - Trompet, Stella A1 - Deshmukh, Harshal A A1 - Barnes, Michael R A1 - Li, Xiaohui A1 - Warren, Helen R A1 - Chasman, Daniel I A1 - Zhou, Kaixin A1 - Arsenault, Benoit J A1 - Donnelly, Louise A A1 - Wiggins, Kerri L A1 - Avery, Christy L A1 - Griffin, Paula A1 - Feng, QiPing A1 - Taylor, Kent D A1 - Li, Guo A1 - Evans, Daniel S A1 - Smith, Albert V A1 - de Keyser, Catherine E A1 - Johnson, Andrew D A1 - de Craen, Anton J M A1 - Stott, David J A1 - Buckley, Brendan M A1 - Ford, Ian A1 - Westendorp, Rudi G J A1 - Slagboom, P Eline A1 - Sattar, Naveed A1 - Munroe, Patricia B A1 - Sever, Peter A1 - Poulter, Neil A1 - Stanton, Alice A1 - Shields, Denis C A1 - O'Brien, Eoin A1 - Shaw-Hawkins, Sue A1 - Chen, Y-D Ida A1 - Nickerson, Deborah A A1 - Smith, Joshua D A1 - Dubé, Marie Pierre A1 - Boekholdt, S Matthijs A1 - Hovingh, G Kees A1 - Kastelein, John J P A1 - McKeigue, Paul M A1 - Betteridge, John A1 - Neil, Andrew A1 - Durrington, Paul N A1 - Doney, Alex A1 - Carr, Fiona A1 - Morris, Andrew A1 - McCarthy, Mark I A1 - Groop, Leif A1 - Ahlqvist, Emma A1 - Bis, Joshua C A1 - Rice, Kenneth A1 - Smith, Nicholas L A1 - Lumley, Thomas A1 - Whitsel, Eric A A1 - Stürmer, Til A1 - Boerwinkle, Eric A1 - Ngwa, Julius S A1 - O'Donnell, Christopher J A1 - Vasan, Ramachandran S A1 - Wei, Wei-Qi A1 - Wilke, Russell A A1 - Liu, Ching-Ti A1 - Sun, Fangui A1 - Guo, Xiuqing A1 - Heckbert, Susan R A1 - Post, Wendy A1 - Sotoodehnia, Nona A1 - Arnold, Alice M A1 - Stafford, Jeanette M A1 - Ding, Jingzhong A1 - Herrington, David M A1 - Kritchevsky, Stephen B A1 - Eiriksdottir, Gudny A1 - Launer, Leonore J A1 - Harris, Tamara B A1 - Chu, Audrey Y A1 - Giulianini, Franco A1 - MacFadyen, Jean G A1 - Barratt, Bryan J A1 - Nyberg, Fredrik A1 - Stricker, Bruno H A1 - Uitterlinden, André G A1 - Hofman, Albert A1 - Rivadeneira, Fernando A1 - Emilsson, Valur A1 - Franco, Oscar H A1 - Ridker, Paul M A1 - Gudnason, Vilmundur A1 - Liu, Yongmei A1 - Denny, Joshua C A1 - Ballantyne, Christie M A1 - Rotter, Jerome I A1 - Adrienne Cupples, L A1 - Psaty, Bruce M A1 - Palmer, Colin N A A1 - Tardif, Jean-Claude A1 - Colhoun, Helen M A1 - Hitman, Graham A1 - Krauss, Ronald M A1 - Wouter Jukema, J A1 - Caulfield, Mark J KW - Cholesterol, LDL KW - Genome-Wide Association Study KW - Humans KW - Hydroxymethylglutaryl-CoA Reductase Inhibitors KW - Pharmacogenetics KW - Polymorphism, Single Nucleotide AB -

Statins effectively lower LDL cholesterol levels in large studies and the observed interindividual response variability may be partially explained by genetic variation. Here we perform a pharmacogenetic meta-analysis of genome-wide association studies (GWAS) in studies addressing the LDL cholesterol response to statins, including up to 18,596 statin-treated subjects. We validate the most promising signals in a further 22,318 statin recipients and identify two loci, SORT1/CELSR2/PSRC1 and SLCO1B1, not previously identified in GWAS. Moreover, we confirm the previously described associations with APOE and LPA. Our findings advance the understanding of the pharmacogenetic architecture of statin response.

VL - 5 U1 - http://www.ncbi.nlm.nih.gov/pubmed/25350695?dopt=Abstract ER - TY - JOUR T1 - Meta-analysis of genome-wide association studies of HDL cholesterol response to statins. JF - J Med Genet Y1 - 2016 A1 - Postmus, Iris A1 - Warren, Helen R A1 - Trompet, Stella A1 - Arsenault, Benoit J A1 - Avery, Christy L A1 - Bis, Joshua C A1 - Chasman, Daniel I A1 - de Keyser, Catherine E A1 - Deshmukh, Harshal A A1 - Evans, Daniel S A1 - Feng, QiPing A1 - Li, Xiaohui A1 - Smit, Roelof A J A1 - Smith, Albert V A1 - Sun, Fangui A1 - Taylor, Kent D A1 - Arnold, Alice M A1 - Barnes, Michael R A1 - Barratt, Bryan J A1 - Betteridge, John A1 - Boekholdt, S Matthijs A1 - Boerwinkle, Eric A1 - Buckley, Brendan M A1 - Chen, Y-D Ida A1 - de Craen, Anton J M A1 - Cummings, Steven R A1 - Denny, Joshua C A1 - Dubé, Marie Pierre A1 - Durrington, Paul N A1 - Eiriksdottir, Gudny A1 - Ford, Ian A1 - Guo, Xiuqing A1 - Harris, Tamara B A1 - Heckbert, Susan R A1 - Hofman, Albert A1 - Hovingh, G Kees A1 - Kastelein, John J P A1 - Launer, Leonore J A1 - Liu, Ching-Ti A1 - Liu, Yongmei A1 - Lumley, Thomas A1 - McKeigue, Paul M A1 - Munroe, Patricia B A1 - Neil, Andrew A1 - Nickerson, Deborah A A1 - Nyberg, Fredrik A1 - O'Brien, Eoin A1 - O'Donnell, Christopher J A1 - Post, Wendy A1 - Poulter, Neil A1 - Vasan, Ramachandran S A1 - Rice, Kenneth A1 - Rich, Stephen S A1 - Rivadeneira, Fernando A1 - Sattar, Naveed A1 - Sever, Peter A1 - Shaw-Hawkins, Sue A1 - Shields, Denis C A1 - Slagboom, P Eline A1 - Smith, Nicholas L A1 - Smith, Joshua D A1 - Sotoodehnia, Nona A1 - Stanton, Alice A1 - Stott, David J A1 - Stricker, Bruno H A1 - Stürmer, Til A1 - Uitterlinden, André G A1 - Wei, Wei-Qi A1 - Westendorp, Rudi G J A1 - Whitsel, Eric A A1 - Wiggins, Kerri L A1 - Wilke, Russell A A1 - Ballantyne, Christie M A1 - Colhoun, Helen M A1 - Cupples, L Adrienne A1 - Franco, Oscar H A1 - Gudnason, Vilmundur A1 - Hitman, Graham A1 - Palmer, Colin N A A1 - Psaty, Bruce M A1 - Ridker, Paul M A1 - Stafford, Jeanette M A1 - Stein, Charles M A1 - Tardif, Jean-Claude A1 - Caulfield, Mark J A1 - Jukema, J Wouter A1 - Rotter, Jerome I A1 - Krauss, Ronald M AB -

BACKGROUND: In addition to lowering low density lipoprotein cholesterol (LDL-C), statin therapy also raises high density lipoprotein cholesterol (HDL-C) levels. Inter-individual variation in HDL-C response to statins may be partially explained by genetic variation.

METHODS AND RESULTS: We performed a meta-analysis of genome-wide association studies (GWAS) to identify variants with an effect on statin-induced high density lipoprotein cholesterol (HDL-C) changes. The 123 most promising signals with p<1×10(-4) from the 16 769 statin-treated participants in the first analysis stage were followed up in an independent group of 10 951 statin-treated individuals, providing a total sample size of 27 720 individuals. The only associations of genome-wide significance (p<5×10(-8)) were between minor alleles at the CETP locus and greater HDL-C response to statin treatment.

CONCLUSIONS: Based on results from this study that included a relatively large sample size, we suggest that CETP may be the only detectable locus with common genetic variants that influence HDL-C response to statins substantially in individuals of European descent. Although CETP is known to be associated with HDL-C, we provide evidence that this pharmacogenetic effect is independent of its association with baseline HDL-C levels.

VL - 53 IS - 12 ER -